Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism FadD32 inhibitors(Fatty acid degradation protein D32 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mycobacterium Tuberculosis, Susceptibility to Infection By | Preclinical | US | 09 Jul 2013 |